“Long Neuro COVID-19 is hypothesized to follow SARS-CoV-2 virus specific pathophysiological changes, with aberrant inflammatory disease and immune responses post-acute infection, similar to that reported with other viral infections including Epstein-Barr Virus (EBV) and associated Chronic Fatigue Syndrome2. Notably patients who had COVID-19 while also infected with EBV were at an increased risk of memory loss7 and EBV infection increases the risk of autoimmune diseases such as Multiple Sclerosis (MS)8 and associated adverse neurological manifestations. ANP’s immunomodulatory drug ATL1102 has previously demonstrated biologic activity in MS patients…”
Itsa :No brainer..
- Forums
- ASX - By Stock
- Ann: Long COVID-19 strategic collaboration with US Experts
“Long Neuro COVID-19 is hypothesized to follow SARS-CoV-2 virus...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.0¢ | $50.72K | 487.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 471705 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 22797 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 471705 | 0.100 |
1 | 13154 | 0.099 |
1 | 13000 | 0.098 |
3 | 180927 | 0.097 |
1 | 10004 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 22797 | 3 |
0.110 | 454450 | 5 |
0.115 | 788451 | 8 |
0.120 | 461389 | 9 |
0.125 | 110429 | 2 |
Last trade - 11.56am 01/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online